Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomasz Wilmanski

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Trends in Microbiology|July 30, 2023
A changing gut virome ecological landscape with longevityTomasz Wilmanski, Sean M Gibbons
Redox Biology|December 30, 2018
D3T acts as a pro-oxidant in a cell culture model of diabetes-induced peripheral neuropathyMateusz A Stochelski, Tomasz Wilmanski, Mitchell Walters, et al.
Breast Cancer Research : BCR|July 15, 2018
Pyruvate carboxylase supports the pulmonary tropism of metastatic breast cancerAparna Shinde, Tomasz Wilmanski, Hao Chen, et al.
The Journal of Nutritional Biochemistry|December 10, 2016
1α,25-dihydroxyvitamin D inhibits de novo fatty acid synthesis and lipid accumulation in metastatic breast cancer cells through down-regulation of pyruvate carboxylaseTomasz Wilmanski, Kimberly Buhman, Shawn S Donkin, et al.
Gut Microbes|April 23, 2021
From taxonomy to metabolic output: what factors define gut microbiome health?Tomasz Wilmanski, Noa Rappaport, Christian Diener, et al.
Nutrition and Cancer|August 24, 2016
1α,25-Dihydroxyvitamin D Inhibits the Metastatic Capability of MCF10CA1a and MDA-MB-231 Cells in an In Vitro Model of Breast to Bone MetastasisTomasz Wilmanski, Alle Barnard, Mukti R Parikh, et al.
Cancer Letters|October 13, 2017
Inhibition of pyruvate carboxylase by 1α,25-dihydroxyvitamin D promotes oxidative stress in early breast cancer progressionTomasz Wilmanski, Xuanzhu Zhou, Wei Zheng, et al.
Nature Metabolism|November 10, 2022
Genome-microbiome interplay provides insight into the determinants of the human blood metabolomeChristian Diener, Chengzhen L Dai, Tomasz Wilmanski, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2020
Longitudinal analysis reveals transition barriers between dominant ecological states in the gut microbiomeRoie Levy, Andrew T Magis, John C Earls, et al.
Nature Biotechnology|September 4, 2019
Blood metabolome predicts gut microbiome α-diversity in humansTomasz Wilmanski, Noa Rappaport, John C Earls, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Trends in Microbiology|July 30, 2023
A changing gut virome ecological landscape with longevityTomasz Wilmanski, Sean M Gibbons
Redox Biology|December 30, 2018
D3T acts as a pro-oxidant in a cell culture model of diabetes-induced peripheral neuropathyMateusz A Stochelski, Tomasz Wilmanski, Mitchell Walters, et al.
Breast Cancer Research : BCR|July 15, 2018
Pyruvate carboxylase supports the pulmonary tropism of metastatic breast cancerAparna Shinde, Tomasz Wilmanski, Hao Chen, et al.
The Journal of Nutritional Biochemistry|December 10, 2016
1α,25-dihydroxyvitamin D inhibits de novo fatty acid synthesis and lipid accumulation in metastatic breast cancer cells through down-regulation of pyruvate carboxylaseTomasz Wilmanski, Kimberly Buhman, Shawn S Donkin, et al.
Gut Microbes|April 23, 2021
From taxonomy to metabolic output: what factors define gut microbiome health?Tomasz Wilmanski, Noa Rappaport, Christian Diener, et al.
Nutrition and Cancer|August 24, 2016
1α,25-Dihydroxyvitamin D Inhibits the Metastatic Capability of MCF10CA1a and MDA-MB-231 Cells in an In Vitro Model of Breast to Bone MetastasisTomasz Wilmanski, Alle Barnard, Mukti R Parikh, et al.
Cancer Letters|October 13, 2017
Inhibition of pyruvate carboxylase by 1α,25-dihydroxyvitamin D promotes oxidative stress in early breast cancer progressionTomasz Wilmanski, Xuanzhu Zhou, Wei Zheng, et al.
Nature Metabolism|November 10, 2022
Genome-microbiome interplay provides insight into the determinants of the human blood metabolomeChristian Diener, Chengzhen L Dai, Tomasz Wilmanski, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2020
Longitudinal analysis reveals transition barriers between dominant ecological states in the gut microbiomeRoie Levy, Andrew T Magis, John C Earls, et al.
Nature Biotechnology|September 4, 2019
Blood metabolome predicts gut microbiome α-diversity in humansTomasz Wilmanski, Noa Rappaport, John C Earls, et al.
Pageof 3